Although not disclosed in the above PR, the Sustiva sales reported by BMY above include 37% of the sales of Atripla (the 3-drug combination pill that contains Sustiva).
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”